View Post

Real-World Study Sheds Light on Treatment Sequences and Second-Line Outcomes in HER2+ Breast Cancer

In In The News by Barbara Jacoby

By: Megan Hollasch From: onclive.com A real-world study published in the International Journal of Clinical Oncology demonstrated that most patients with HER2-positive metastatic breast cancer discontinued second-line treatment in US community practices, which study authors noted underscores the need for timely second-line treatment. Findings from the retrospective cohort revealed that at a median follow-up of 22 months (IQR, 13-37) from …

View Post

Navigating breast cancer surgery

In In The News by Barbara Jacoby

By: Susan Cunningham From: uchealth.org A breast cancer diagnosis is never welcome, but with advances in breast cancer surgery, it may be more manageable than many women assume. “I think a lot of women historically think that if they have breast cancer, they’re going to need a mastectomy, which is not true in most cases,” said Dr. Zach Hartman, a …

View Post

Rice scientists identify promising new immunological pathway to treat breast cancer bone metastases

In In The News by Barbara Jacoby

Source: Rice University From: news-medical.net Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients. “More than 70% of people with metastatic breast cancer will see the cancer cells move to bone, which can lead to skeletal-related …

View Post

Health supplement MitoQ world’s first to stop breast cancer recurrence and spread?

In In The News by Barbara Jacoby

By: Study Finds From: studyfinds.org In a world-first, scientists have found a drug that can halt the recurrence and spread of breast cancer. The treatment, called the MitoQ molecule, stopped cancer’s spread in 80 percent of cases and recurrence in 75 percent of patients. Researchers in Belgium are calling the discovery a “giant step” in beating the disease. After originally …

View Post

The first AI breast cancer sleuth that shows its work New AI for mammography scans aims to aid rather than replace human decision-making

In In The News by Barbara Jacoby

Source: Duke University From: sciencedaily.com Computer engineers and radiologists at Duke University have developed an artificial intelligence platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, this algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions. The researchers trained the …

View Post

Sedentary Cancer Survivors See Far Worse Survival

In In The News by Barbara Jacoby

By: Ian Ingram From: medpagetoday.com More than a third of patients reported no activity along with 6 or more hours of sitting per day Cancer survivors with prolonged daily sitting and little to no physical activity had a far higher chance of death, whether from their cancer or other causes, a cohort study found. In the prospective study of more …

View Post

Metabolic memory plays a key role in breast cancer relapse

In In The News by Barbara Jacoby

Source: EMBO From: sciencedaily.com Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of German, Norwegian and British scientists who analyzed tumour cells that proved resistant to the original treatment. Recent advances in early detection and targeted therapy have led to a growing success in treating breast cancer upon first presentation. This often …